Avanir Vice President and General Counsel Garlan Adams Featured in Modern Counsel

September 15, 2017

In this interview with Modern Counsel magazine, Avanir VP and General Counsel Garlan Adams shares her thoughts on how the biotechnology and pharmaceutical industry is transforming disease treatment. Based on her 18 years of industry experience, Garlan describes the challenges of the drug development funnel – the long and costly process of bringing new treatments to market – and the importance of defining “success” as a patient would see it, not simply as having won regulatory approval for patient use.

 Source: http://modern-counsel.com/2017/garlan-adams-avanir-pharmaceuticals/